Your browser doesn't support javascript.
loading
Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation.
Bigley, Venetia; Maisuria, Sheetal; Cytlak, Urszula; Jardine, Laura; Care, Matthew A; Green, Kile; Gunawan, Merry; Milne, Paul; Dickinson, Rachel; Wiscombe, Sarah; Parry, David; Doffinger, Rainer; Laurence, Arian; Fonseca, Claudia; Stoevesandt, Oda; Gennery, Andrew; Cant, Andrew; Tooze, Reuben; Simpson, A John; Hambleton, Sophie; Savic, Sinisa; Doody, Gina; Collin, Matthew.
Afiliação
  • Bigley V; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom. Electronic address: Venetia.bigley@ncl.ac.uk.
  • Maisuria S; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
  • Cytlak U; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Jardine L; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Care MA; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
  • Green K; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Gunawan M; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Milne P; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Dickinson R; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Wiscombe S; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Parry D; Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom.
  • Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Laurence A; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Fonseca C; Cambridge Protein Arrays, Babraham Research Campus, Cambridge, United Kingdom.
  • Stoevesandt O; Cambridge Protein Arrays, Babraham Research Campus, Cambridge, United Kingdom.
  • Gennery A; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Cant A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Tooze R; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
  • Simpson AJ; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Hambleton S; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Savic S; National Institute for Health Research-Leeds Musculoskeletal Biomedical Research Unit and Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
  • Doody G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
  • Collin M; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
J Allergy Clin Immunol ; 141(6): 2234-2248, 2018 06.
Article em En | MEDLINE | ID: mdl-29128673
ABSTRACT

BACKGROUND:

The homozygous K108E mutation of interferon regulatory factor 8 (IRF8) is reported to cause dendritic cell (DC) and monocyte deficiency. However, more widespread immune dysfunction is predicted from the multiple roles ascribed to IRF8 in immune cell development and function.

OBJECTIVE:

We sought to describe the effect on hematopoiesis and immunity of the compound heterozygous R83C/R291Q mutation of IRF8, which is present in a patient with recurrent viral infection, granuloproliferation, and intracerebral calcification.

METHODS:

Variant IRF8 alleles were identified by means of exome sequencing, and their function was tested by using reporter assays. The cellular phenotype was studied in detail by using flow cytometry, functional immunologic assay transcriptional profiling, and antigen receptor profiling.

RESULTS:

Both mutations affected conserved residues, and R291Q is orthologous to R294, which is mutated in the BXH2 IRF8-deficient mouse. R83C showed reduced nuclear translocation, and neither mutant was able to regulate the Ets/IRF composite element or interferon-stimulated response element, whereas R291Q retained BATF/JUN interactions. DC deficiency and monocytopenia were observed in blood, dermis, and lung lavage fluid. Granulocytes were consistently increased, dysplastic, and hypofunctional. Natural killer cell development and maturation were arrested. TH1, TH17, and CD8+ memory T-cell differentiation was significantly reduced, and T cells did not express CXCR3. B-cell development was impaired, with fewer memory cells, reduced class-switching, and lower frequency and complexity of somatic hypermutation. Cell-specific gene expression was widely disturbed in interferon- and IRF8-regulated transcripts.

CONCLUSIONS:

This analysis defines the clinical features of human biallelic IRF8 deficiency, revealing a complex immunodeficiency syndrome caused by DC and monocyte deficiency combined with widespread immune dysregulation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores Reguladores de Interferon / Síndromes de Imunodeficiência Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores Reguladores de Interferon / Síndromes de Imunodeficiência Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2018 Tipo de documento: Article